(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 5. The AKT downstream proteins and EG cell lines derived from p53-deficient
mice. (A-C) Immunostaining with antibodies against phospho-GSK3
(A), MDM2 (B) and Ser20-phospho-p53 (C). The AKT-MER transgenic PGCs were
cultured for 2 days in the presence of the indicated reagents. The cells were
stained with antibodies against AKT downstream molecules (red) and germ cell
markers SSEA-1 or PGC7/Stella (green). Yellow and white arrowheads indicate
the stained and unstained PGCs, respectively. The percentage of positive cells
is shown below each picture. The percentage of phospho-GSK3-positive PGCs (A)
and of PGCs stained strongly with MDM2 antibody (B) was significantly higher
in the 4OHT-treated PGCs, irrespective of bFGF treatment
(*P<0.005,
2 test), than in wild type.
The percentage of phospho-p53-positive PGCs cultured without 4OHT and bFGF was
significantly higher than that of other groups
(*P<0.005,
2 test; C). More than 300
PGCs were analyzed in each group. Scale bars: 25 µm. (D) EG cell
lines derived from p53-deficient mice. EG cell lines were established in the
presence (left) or absence (right) of bFGF. Scale bar: 100 µm.